Director · MADRIGAL PHARMACEUTICALS, INC. · MADRIGAL PHARMACEUTICALS, INC. — Stock Option (Right to Buy)
Side
M
Value
—
Shares
4,000
Price
—
Executed
Jan 26, 2026
Disclosed
Jan 26, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Jan 26 executedJan 26, 2026 disclosed
MDGL · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
MADRIGAL PHARMACEUTICALS, INC. — Stock Option (Right to Buy)
Ticker
MDGL
Shares
4,000
Price per share
$0
Execution date (reported)
Jan 26, 2026
Owned after transaction
0 shares
Days from execution to publication
0
What this establishes
Levy Richard S filed this Form 4 reporting a option exercise of MDGL on Jan 26, 2026. It became public on Jan 26, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Levy Richard Scik:0001454983
Issuer
MADRIGAL PHARMACEUTICALS, INC.cik:0001157601
Revision history · 0
No field has changed since this record was first ingested.
